Miragen Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $127k | 5.9k | 21.58 |
| 2025-06-30 | $99k | 7.1k | 13.98 |
| 2025-03-31 | $103k | 7.6k | 13.48 |
| 2024-12-31 | $147k | 7.6k | 19.17 |
| 2024-09-30 | $140k | 6.1k | 22.75 |
| 2024-06-30 | $80k | 6.1k | 13.01 |
| 2024-03-31 | $87k | 5.0k | 17.51 |
| 2023-12-31 | $91k | 4.2k | 21.78 |
| 2023-09-30 | $64k | 4.2k | 15.34 |
| 2023-06-30 | $83k | 3.5k | 23.79 |
| 2023-03-31 | $77k | 3.0k | 25.44 |
| 2022-12-31 | $108k | 3.0k | 35.64 |
| 2022-09-30 | $39k | 1.9k | 20.16 |
| 2022-06-30 | $22k | 1.9k | 11.37 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors